Pearl Cohen Senior Partner Ilan Gerzi represented InterCure Ltd. (TASE: INCR-M) in publishing a rights offering prospectus on the Tel Aviv Stock Exchange (TASE). InterCure Ltd., a public company in the medical device industry, recently signed a term sheet to invest in Regenera Pharma Ltd., an Israeli private bio-medical company. InterCure Ltd. is offering ordinary shares and tradable options (series 1) in an aggregate amount of approximately NIS 33 million. The offering is scheduled to be completed by March 22, 2015. CLICK HERE and HERE for the articles.